FDA — authorised 28 May 1982
- Marketing authorisation holder: KING PHARMS
- Status: approved
🇺🇸 Intal in United States
FDA authorised Intal on 28 May 1982
Marketing authorisations
FDA — authorised 28 May 1982
- Application: NDA018596
- Marketing authorisation holder: KING PHARMS LLC
- Local brand name: INTAL
- Indication: SOLUTION — INHALATION
- Status: approved
FDA — authorised 5 December 1985
- Application: NDA018887
- Marketing authorisation holder: KING PHARMS LLC
- Local brand name: INTAL
- Indication: AEROSOL, METERED — INHALATION
- Status: approved
Intal in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Respiratory approved in United States
Frequently asked questions
Is Intal approved in United States?
Yes. FDA authorised it on 28 May 1982; FDA authorised it on 28 May 1982; FDA authorised it on 5 December 1985.
Who is the marketing authorisation holder for Intal in United States?
KING PHARMS holds the US marketing authorisation.